Taysha Gene Therapies
Latest round
- Series B
Last raised
- Jul 2020
Total raised
- $114M
Investors
- 13
About Taysha Gene Therapies
Taysha Gene Therapies, Inc.Founded in 2020 and headquartered in Dallas, US, Taysha Gene Therapies, Inc. focuses on developing innovative gene therapies. The company has undergone strategic efforts to secure partnerships within the healthcare sector. Sean Nolan serves as CEO.Taysha Gene Therapies is dedicated to discovering and commercializing gene therapies for monogenic diseases affecting the CNS. Their leading product, TSHA-102, targets Rett syndrome, a genetic disorder leading to severe intellectual disability in females. The company utilizes advanced gene therapy techniques to address genetic mutations and enhance life quality for patients.21 mn.Taysha Gene Therapies plans to launch new products, including the TSHA-102 gene therapy for Rett syndrome.
Who invested in Taysha Gene Therapies
13 investors across 2 rounds
See all investors in Taysha Gene Therapies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Taysha Gene Therapies
Who invested in Taysha Gene Therapies?
Taysha Gene Therapies has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Taysha Gene Therapies raised?
Taysha Gene Therapies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Taysha Gene Therapies last raise money?
Taysha Gene Therapies's most recent round on record is a Series B, in Jul 2020.
What does Taysha Gene Therapies do?
Taysha Gene Therapies is a biotechnology company.
Where is Taysha Gene Therapies headquartered?
Taysha Gene Therapies is headquartered in Dallas, US.
Which VCs invest in companies like Taysha Gene Therapies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Taysha Gene Therapies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Taysha Gene Therapies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.